Google Alert - "Myeloproliferative neoplasms" OR "polycythemia vera" OR myelofibrosis OR "essential thrombocythemia" google.com

Prelude Therapeutics Receives FDA Clearance of Investigational New Drug Application ...

google.com·15w

Why Did PRLD Stock Surge 13% Today?

google.com·15w

Early Data for Tagraxofusp Support Further Evaluation in Combination Therapies in Myelofibrosis

google.com·15w

Prelude Therapeutics Receives FDA Clearance of Investigational New Drug Application ...

google.com·15w

Prelude Therapeutics Inc FDA Clearance for PRT12396 Phase 1 Study

google.com·15w

Prelude Therapeutics gets FDA clearance for JAK2 inhibitor trial

google.com·15w

Sequential treatment with ruxolitinib and imetelstat effectively depletes myelofibrosis ...

google.com·15w

Key Oncology Drugs Granted FDA Designations in January 2026

google.com·15w

World Cancer Day 2026: How Precision Onco-Haematology Is Personalising Blood ...

google.com·15w

SNT: Multiple clinical milestones and strong funding position set the stage for a pivotal 2026

google.com·15w

Mark Trifiro avis de décès - Austin, TX

google.com·15w

JAK2V617F reprograms Hypoxia Inducible Factor-1 to induce a non-canonical hypoxia ...

google.com·15w

Ropeginterferon Alfa Gains NCCN Backing in Essential Thrombycythemia

google.com·15w

FDA Grants Orphan Drug Designation to Zavabresib for Treating Myelofibrosis

google.com·15w

FDA Grants Orphan Drug Designation to Zavabresib for the Treatment of Myelofibrosis

google.com·15w

Shilpa Medicare & mAbTree Biologics win FDA nod for rare blood cancer therapy

google.com·15w

Novel Targeted Agents Are Poised to Influence the MPN Treatment Paradigm

google.com·15w

USFDA Grants Orphan Drug Status to Shilpa-mAbTree Biologic for Rare Blood Cancers

google.com·16w

Shilpa Medicare unit gets USFDA orphan drug tag for new biologic

google.com·16w

Myelofibrosis , hematologist Passamonti: "Momelotinib improves hemoglobin levels."

google.com·16w

Log in to enable infinite scrolling